Sanofi CEO Chris Viehbacher is going direct to several key Genzyme shareholders.
"Due to the great interest in Sanofi-Aventis' offer, Mr. Viehbacher has decided to set aside the time to meet with a selction of Genzyme shareholders to discuss the proposal while in the country for other previously scheduled meetings" said Sanofi spokesman.
Viehbacher will attempt to find out the true asking price to swing these shareholders - and you can bet he's looking for a price well below the $80 per share that Termeer and the Board have floated publicly. See Fierce Biotech.
Posted by Bruce Lehr September 8th 2010.
The very latest (Sept 8th) from Reuters says Sanofi has pitched $71 per share
http://uk.reuters.com/article/idUKTRE6873GD20100908?rpc=401&feedType=RSS&feedName=euDealsNews&rpc=401
Posted by: bigredbruce | 09/08/2010 at 04:10 PM